Should we be prepared to change the population composition of a species in order to wipe out a disease that is a terrible burden to mankind? During a well-attended working breakfast organised by the European Parliament’s Panel for the Future of Science and Technology (STOA) on 19 March 2019, experts and citizens delved into the case study of eradicating malaria by applying gene-drive technology. This genetic tool could enable us to suppress mosquito populations that transmit malaria by reducing the number of females. This would be done by introducing in some mosquitos a genetic mechanism that easily spreads – ‘drives’ – through the whole population over generations.
The purpose of the event was to gain insight into the science and ethics of gene-drive technology, and of genome-editing technologies in general. The meeting was chaired by Kay Swinburne, (ECR, UK) a STOA Panel member, who underlined the importance of invigorating public debate on such technologies in her opening statement. With more than 200 million cases of malaria each year worldwide, of which over 400 000 are fatal, no one doubts the importance of fighting this disease. This, as Kay Swinburne explained, makes the case less controversial than, for instance, human genome editing, and therefore it provides a good opportunity to focus on understanding the benefits of genetic technology. Such an understanding, combined with knowledge of the risks and concerns, and with awareness of different stakeholder perspectives, should help policy-makers anticipate the application of genome-editing technologies. With three expert presentations and a debate, this event provided input on all these fronts.
First, Jens Van Steerteghem, of KU Leuven, and a former STOA trainee, gave the audience a technical overview of gene-drive technology in the context of eradicating malaria. His presentation was based on a scientific briefing that was used in a preliminary foresight analysis project on gene drive and malaria. This project aimed to map the potential societal impact of gene-drive technology and exposed the need for a general risk assessment framework for biotechnological applications. Jens Steerteghem explained how the number of female mosquitos would be suppressed if the gene-drive method were applied: by introducing in males a gene on the Y chromosome that cuts their X chromosome, so that they only pass Y chromosomes to their offspring. This offspring are consequently exclusively male, and additionally carry the new gene on their Y chromosome.
Delphine Thizy, Stakeholder Engagement Manager with the non-profit research organisation Target Malaria delivered the second presentation. This organisation is developing the gene-drive technology method to reduce malaria. Delphine Thizy described the current state of the research at her organisation, commenting that only in September 2018, their team published a paper on a successful eradication experiment on a mosquito population in a containment cage. She also addressed some of the misconceptions and concerns she hears when explaining Target Malaria’s plans. These worries are expressed both by citizens in Western countries but also, and more importantly, from stakeholders in countries in sub-Saharan Africa that suffer from malaria. People question, for example, if the targeted mosquito species are crucial pollinators, or if the reduction of mosquitos would disturb food chains. For both cases, she indicated that there is no need to worry: the targeted mosquitoes are not known to be pollinators and just three mosquito species would be targeted out of 830 species in Africa alone.
NanoApps Medical, Inc. Aims To Develop Nanobiosensor for Malaria, Ebola, and Zika
News This Week
Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks. Unlike N95 masks, the new masks were designed [...]
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned. Neurologists are on Wednesday publishing details of [...]
University of Wisconsin-Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination -- including a COVID-19 vaccine from Moderna [...]
Despite its advantages over other vaccine technologies for Covid-19, adenovirus vector vaccines are likely to be tripped up by pre-existing antibodies to the vectors used and the need for a second injection to boost [...]
When the first coronavirus cases in Chicago appeared in January, they bore the same genetic signatures as a germ that emerged in China weeks before. But as Egon Ozer, an infectious-disease specialist at the Northwestern University [...]
Park Systems presents “NanoScientific Symposium on Nano Applications for a Changing World” sponsored by Physics World and Nanotechnology World Association. Park Systems launched this online event for researchers and scientists in nanoscience and nanotechnology [...]
Notwithstanding the wishful thinking of certain irresponsible and incompetent public figures, the only options to control and deal with the spread of the Severe Acute Respiratory Syndrome Virus 2 (SARS-CoV-2) are fast, cheap, reliable, [...]
From the Annals of Neurology: In less than 6 months, the severe acute respiratory syndrome‐coronavirus type 2 (SARS‐CoV‐2) has spread worldwide infecting nearly 6 million people and killing over 350,000. Initially thought to be restricted [...]
A cheap steroid has become the first life-saving treatment in the Covid-19 pandemic, described by scientists as a major breakthrough and raising hopes for the survival of thousands of the most seriously ill. Dexamethasone [...]
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study will be the first time the vaccine has been trialled in humans [...]
A form of the novel coronavirus which has become the dominant type in much of the world may have done so thanks to a mutation that allows it to better latch onto human hosts’ [...]
A widely available and inexpensive drug that is used to ease the symptoms of indigestion may prove a worthy contender for treating COVID-19 infection in those whose disease doesn’t require admission to hospital, suggest [...]
One of the most common COVID-19 tests involves a long swab pressed deep into the nasal cavities – and while the test can be administered quickly, it has been described as unpleasant and uncomfortable. [...]
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear: 1 June — Positive coronavirus test is no guarantee of infectiousness People with COVID-19 are unlikely to [...]
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form of pneumonia. Quickly after came [...]
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay [...]